Affinage

LRRC58

Leucine-rich repeat-containing protein 58 · UniProt Q96CX6

Length
371 aa
Mass
40.6 kDa
Annotated
2026-04-28
10 papers in source corpus 11 papers cited in narrative 5 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

LRRC58 is a leucine-rich repeat protein that functions as the substrate adaptor of a CUL2/CUL5-based cullin-RING E3 ubiquitin ligase complex, targeting cysteine dioxygenase 1 (CDO1) for proteasomal degradation at Lys8 to maintain cysteine homeostasis (PMID:40963025, PMID:41270722). LRRC58 stability is itself inversely regulated by cysteine availability: cysteine-replete conditions trigger LRRC58 auto-ubiquitination and self-degradation, whereas cysteine deprivation stabilizes LRRC58 to promote CDO1 turnover, thereby preventing ferroptotic cell death caused by futile cysteine catabolism (PMID:40963025). In mice, hepatocyte-specific LRRC58 depletion stabilizes CDO1, redirecting cysteine flux toward taurine and bile acid conjugation and lowering hepatic cholesterol (PMID:40963025). Independently of its protein-coding function, the Lrrc58 3′ UTR serves as a target-directed miRNA degradation (TDMD) trigger RNA that recruits miR-503-5p to AGO for ZSWIM8-dependent destruction, and deletion of this trigger site in mice causes miR-503-dependent embryonic growth restriction (PMID:41213800, PMID:40631113).

Mechanistic history

Synthesis pass · year-by-year structured walk · 4 steps
  1. 2025 Medium

    Establishing that LRRC58 ortholog lrr-2 post-translationally controls CDO1 levels in C. elegans revealed a conserved regulatory axis in sulfur amino acid metabolism, answering the question of how cysteine dioxygenase abundance is tuned across metazoans.

    Evidence Forward genetic selection and epistasis analysis in C. elegans with H₂S rescue experiments

    PMID:39786993

    Open questions at the time
    • Single-lab genetic study in a model organism; biochemical mechanism of regulation not defined
    • Direct physical interaction between lrr-2 and cdo-1 not demonstrated
    • No mammalian validation at that time
  2. 2025 High

    Identification of LRRC58 as the substrate adaptor of a CUL2/CUL5 E3 ligase complex that ubiquitylates CDO1 at Lys8, combined with cryo-EM structure and demonstration that cysteine abundance inversely regulates LRRC58 stability via auto-ubiquitination, established the complete molecular logic of a nutrient-sensing degradation switch for cysteine homeostasis.

    Evidence Metabolite-protein covariation mass spectrometry, cryo-EM structural analysis, biochemical reconstitution of CRL complex, saturation mutagenesis stability profiling, active CRL profiling, and in vivo hepatocyte depletion in mice across multiple independent laboratories

    PMID:40963025 PMID:41270722

    Open questions at the time
    • Structural basis for cysteine sensing by LRRC58 (how cysteine triggers auto-ubiquitination) not fully resolved
    • Whether additional substrates beyond CDO1 are targeted by the LRRC58-CRL complex is unknown
    • Tissue-specific regulation outside liver not characterized
  3. 2025 Medium

    Demonstrating that LRRC58-mediated CDO1 degradation prevents ferroptosis under cysteine scarcity, and that patient CDO1 mutations causing neurodevelopmental defects escape LRRC58 recognition, linked this ubiquitin ligase axis to human disease and cell survival.

    Evidence Cell death assays under cysteine deprivation, saturation mutagenesis of CDO1-LRRC58 binding interface, analysis of patient-derived CDO1 mutations (preprint)

    PMID:bio_10.1101_2025.09.23.678073

    Open questions at the time
    • Preprint not yet peer-reviewed; disease-causative CDO1 mutations need independent clinical validation
    • Whether LRRC58 loss alone is sufficient for ferroptosis in vivo is untested
    • Mechanism by which dominant-active CDO1 mutants evade LRRC58 recognition not structurally defined
  4. 2025 High

    Discovery that the Lrrc58 3′ UTR functions as a TDMD trigger RNA for miR-503-5p, driving ZSWIM8-dependent AGO degradation and miRNA turnover, revealed a second, protein-coding-independent biological function of the LRRC58 locus in controlling embryonic body growth.

    Evidence AGO-CLASH, CRISPR deletion of the trigger site in the mouse Lrrc58 3′ UTR, body size phenotyping, miRNA quantification; independently replicated by two laboratories

    PMID:40631113 PMID:41213800 PMID:41279844 PMID:41871909

    Open questions at the time
    • Whether the TDMD function and the CRL adaptor function interact or are independently regulated is unknown
    • The full spectrum of miRNAs regulated by the Lrrc58 3′ UTR beyond miR-503-5p is not defined
    • Mechanism linking miR-503-5p to embryonic growth restriction at the target mRNA level is uncharacterized

Open questions

Synthesis pass · forward-looking unresolved questions
  • Open questions remain about how cysteine is sensed to toggle LRRC58 auto-ubiquitination, whether LRRC58 targets substrates beyond CDO1, and how the dual functions of the LRRC58 locus (CRL adaptor protein and TDMD trigger mRNA) are coordinated in physiology.
  • Cysteine-sensing mechanism upstream of LRRC58 stabilization is undefined
  • No systematic substrate profiling beyond CDO1
  • Interplay between LRRC58 protein function and 3′ UTR TDMD activity unexplored

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0060090 molecular adaptor activity 3 GO:0140096 catalytic activity, acting on a protein 1
Localization
GO:0005829 cytosol 1
Pathway
R-HSA-1430728 Metabolism 3 R-HSA-392499 Metabolism of proteins 3 R-HSA-8953854 Metabolism of RNA 1
Complex memberships
CUL2-LRRC58 CRL complexCUL5-LRRC58 CRL complex

Evidence

Reading pass · 5 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2025 LRRC58 is the substrate adaptor of a CUL2-based (and CUL5-based) E3 ubiquitin ligase complex (CRL) that mediates proteasomal degradation of CDO1 (cysteine dioxygenase 1), the rate-limiting enzyme of cysteine catabolism to taurine. Cysteine abundance regulates LRRC58 stability inversely: under cysteine-replete conditions, LRRC58 undergoes auto-ubiquitination and proteasomal self-degradation; under cysteine deprivation, LRRC58 is stabilized and promotes CDO1 ubiquitylation specifically at Lys8. Covariation mass spectrometry (metabolite-protein covariation architecture), biochemical reconstitution of CRL complex, cryo-EM structural analysis, saturation mutagenesis stability profiling, quantitative proteomics, active cullin-RING ligase profiling, cellular depletion experiments in hepatocytes/mice Nature / bioRxiv High 40963025 41270722 bio_10.1101_2025.09.23.678073 bio_10.1101_2025.11.14.688510
2025 Depletion of LRRC58 in hepatocytes stabilizes CDO1, driving increased cysteine flux to taurine, which promotes bile acid conjugation and lowers hepatic cholesterol in mice, demonstrating that the LRRC58-CDO1 axis controls liver cysteine utilization and cholesterol handling. Hepatocyte-specific LRRC58 depletion in mice, metabolite flux measurements, cholesterol assays Nature High 40963025
2025 LRRC58-mediated CDO1 degradation is essential to prevent ferroptotic cell death under conditions of cysteine scarcity; CDO1 mutations causing human neurodevelopmental defects encode dominant-active proteins refractory to LRRC58 recognition, placing LRRC58-CDO1 as a critical regulator of cysteine homeostasis safeguarding neural development. Cell death assays under cysteine deprivation, saturation mutagenesis of CDO1-LRRC58 interface, analysis of patient-derived CDO1 mutations bioRxivpreprint Medium bio_10.1101_2025.09.23.678073
2025 The 3' UTR of Lrrc58 mRNA acts as a TDMD (target-directed microRNA degradation) trigger for miR-503-5p: binding of miR-503-5p to the Lrrc58 3' UTR induces ZSWIM8-dependent ubiquitylation and decay of associated AGO proteins, leading to miR-503-5p turnover. Deletion of this trigger site in mice abrogates TDMD of miR-503-5p and causes miR-503-dependent embryonic growth restriction. AGO cross-linking and sequencing of hybrids (AGO-CLASH), CRISPR deletion of trigger site in mouse 3' UTR, mouse body size phenotyping, miRNA quantification Genes & development / bioRxiv High 40631113 41213800 41279844 41871909 bio_10.1101_2025.06.30.662380 bio_10.1101_2025.11.06.686990
2025 In C. elegans, the ortholog lrr-2/LRRC58 post-translationally regulates levels of cysteine dioxygenase (cdo-1/CDO1), placing lrr-2 in the animal sulfur metabolism pathway controlling cysteine and H2S production, as established by genetic epistasis in a forward selection screen. Forward genetic selection, genetic epistasis in C. elegans, mutant allele analysis, exogenous H2S rescue experiments Cell reports Medium 39786993

Source papers

Stage 0 corpus · 10 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2016 [IDENTIFICATION OF A NEW DIAGNOSTIC MARKERS OF PROSTATIC CANCER, USING NOTI-MICROCHIPS]. Klinichna khirurhiia 7 27434957
2025 Hydrogen sulfide mediates the interaction between C. elegans and Actinobacteria from its natural microbial environment. Cell reports 6 39786993
2022 Evaluation of a Pooling Chemoproteomics Strategy with an FDA-Approved Drug Library. Biochemistry 5 35969671
2025 Covariation MS uncovers a protein that controls cysteine catabolism. Nature 4 40963025
2022 Identification of genes modified by N6-methyladenosine in patients with colorectal cancer recurrence. Frontiers in genetics 4 36324506
2026 Plagl1 and Lrrc58 control mammalian body size by triggering target-directed microRNA degradation of miR-322 and miR-503. Genes & development 2 41213800
2025 Plagl1 and Lrrc58 control mammalian body size by triggering target-directed microRNA degradation of miR-322 and miR-503. bioRxiv : the preprint server for biology 2 40631113
2025 mRNA 3' UTRs direct microRNA degradation to participate in imprinted gene networks and regulate growth. bioRxiv : the preprint server for biology 2 41279844
2026 mRNA 3' UTRs direct microRNA degradation to participate in imprinted gene networks and regulate growth. Genes & development 0 41871909
2025 Leveraging biochemical covariance to better understand biology. Molecular cell 0 41270722